Here are some of the stocks that may see significant price movement today.
IndiGo: The aviation business’ co-founder Rakesh Gangwal is planning to pare up to 3.4% stake in the airline’s parent company via block deal. This deal has a total consideration of ₹6,831 Crore. The floor price for it has been decided at ₹5,175 per share, this is nearly 4.5% lower than the current market price.
Lupin: The drugmaker announced a licensing and supply agreement with SteinCares for its biosimilar Ranibizumab in Latin America. This excludes Mexico and Argentina. This biosimilar can be used for the treatment of several retinal disorders.
Nazara Tech: The online gaming business posted its results for the quarter ended March 2025 and logged a net profit of ₹4 Crore. In the previous corresponding quarter, the business posted a net profit of ₹18 Lakh. The company’s revenue from operations witnessed a 95% growth in Q4FY25 at ₹520.20 Crore. In the same quarter of previous year, the business posted a revenue of ₹266.20 Crore.
Aurobindo Pharma: The pharma business posted a 11% year-on-year growth in its consolidated revenue of ₹8,382.10 Crore. The topline growth was fueled by a 13.50% y-o-y jump in US formulation sales and a 17.20% growth in European formulations.
DLF: The real estate developer is planning to unveil its much awaited premium housing project in Mumbai in the next two weeks.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.